Go Pro

IntelGenx Technologies (IGXT) 10K Form and Latest SEC Filings 2026

IntelGenx Technologies logo
$0.17 0.00 (0.00%)
As of 09/1/2026

Latest IntelGenx Technologies SEC Filings & Recent Activity

IntelGenx Technologies (OTCMKTS:IGXT) has submitted 180+ documents to the U.S. Securities and Exchange Commission (SEC) since 2017. For investors, these filings are the primary source of verified financial data — covering everything from annual revenue and debt levels in the 10-K, to material business events in 8-K current reports, to insider buying and selling activity in Form 4 disclosures. The most recent filing was a Form NT 10-Q submitted on August 14, 2024.

DateFilerForm TypeView
08/14/2024 2:45 PM
IntelGenx Technologies (1098880) Filer
Form NT 10-Q
07/23/2024 3:00 PM
IntelGenx Technologies (1098880) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/14/2024 11:15 PM
IntelGenx Technologies (1098880) Filer
Form EFFECT
07/14/2024 11:15 PM
IntelGenx Technologies (1098880) Filer
Form EFFECT
07/14/2024 11:15 PM
IntelGenx Technologies (1098880) Filer
Form EFFECT
07/14/2024 11:15 PM
IntelGenx Technologies (1098880) Filer
Form EFFECT
07/14/2024 11:15 PM
IntelGenx Technologies (1098880) Filer
Form EFFECT
07/14/2024 11:15 PM
IntelGenx Technologies (1098880) Filer
Form EFFECT
07/14/2024 11:15 PM
IntelGenx Technologies (1098880) Filer
Form EFFECT
07/14/2024 11:15 PM
IntelGenx Technologies (1098880) Filer
Form EFFECT
07/08/2024 4:15 PM
IntelGenx Technologies (1098880) Filer
Form POS AM
07/08/2024 4:15 PM
IntelGenx Technologies (1098880) Filer
Form POS AM
07/08/2024 4:16 PM
IntelGenx Technologies (1098880) Filer
Form POS AM
07/08/2024 4:16 PM
IntelGenx Technologies (1098880) Filer
Form POS AM
07/08/2024 4:17 PM
IntelGenx Technologies (1098880) Filer
Form POS AM
07/08/2024 4:18 PM
IntelGenx Technologies (1098880) Filer
Form POS AM
07/08/2024 4:18 PM
IntelGenx Technologies (1098880) Filer
Form POS AM
07/08/2024 4:19 PM
IntelGenx Technologies (1098880) Filer
Form S-8 POS
07/08/2024 4:20 PM
IntelGenx Technologies (1098880) Filer
Form S-8 POS
07/08/2024 4:20 PM
IntelGenx Technologies (1098880) Filer
Form S-8 POS
07/08/2024 4:21 PM
IntelGenx Technologies (1098880) Filer
Form S-8 POS
07/08/2024 4:21 PM
IntelGenx Technologies (1098880) Filer
Form S-8 POS
07/08/2024 4:22 PM
IntelGenx Technologies (1098880) Filer
Form S-8 POS
07/08/2024 4:22 PM
IntelGenx Technologies (1098880) Filer
Form S-8 POS
07/08/2024 4:23 PM
IntelGenx Technologies (1098880) Filer
Form S-8 POS
07/08/2024 1:50 PM
IntelGenx Technologies (1098880) Filer
Form POS AM
05/24/2024 2:49 PM
IntelGenx Technologies (1098880) Filer
Form 1-A-W
05/21/2024 7:00 AM
IntelGenx Technologies (1098880) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2024 3:16 PM
IntelGenx Technologies (1098880) Filer
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/03/2024 3:05 PM
ATAI Life Sciences AG (1776242) Reporting
ATAI Life Sciences N.V. (1840904) Reporting
IntelGenx Technologies (1098880) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2024 3:06 PM
ATAI Life Sciences N.V. (1840904) Filed by
IntelGenx Technologies (1098880) Subject
Form SC 13D/A
04/12/2024 2:32 PM
IntelGenx Technologies (1098880) Filer
Form 253G2
04/11/2024 11:15 PM
IntelGenx Technologies (1098880) Filer
Form QUALIF
04/05/2024 4:06 PM
IntelGenx Technologies (1098880) Filer
Form 1-A POS
03/25/2024 3:06 PM
IntelGenx Technologies (1098880) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/21/2024 7:00 AM
IntelGenx Technologies (1098880) Filer
Form DEF 14A
03/21/2024 7:00 AM
IntelGenx Technologies (1098880) Filer
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/12/2024 8:36 PM
ATAI Life Sciences AG (1776242) Reporting
ATAI Life Sciences N.V. (1840904) Reporting
IntelGenx Technologies (1098880) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2024 8:30 PM
ATAI Life Sciences N.V. (1840904) Filed by
IntelGenx Technologies (1098880) Subject
Form SC 13D/A
02/20/2024 4:25 PM
IntelGenx Technologies (1098880) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/20/2024 1:07 PM
IntelGenx Technologies (1098880) Filer
Form 253G2
The cat is out the bag (Ad)

Almost 80,000 tech jobs vanished in the first three months of 2026. Meta cut 14,000 roles, Microsoft offered separation packages to 8,500 workers, and Oracle is reportedly eliminating up to 30,000 positions. Goldman Sachs estimates 12,400 Americans are being financially displaced every single day. Analyst Porter Stansberry says the real driver runs deeper than AI - and two Nobel Prize winners have issued the same warning. He calls it the Final Displacement, and he's releasing a full investigation with specific companies to buy and sell before the next wave hits.tc pixel

Watch Porter Stansberry's full investigation into the Final Displacement now
02/19/2024 11:15 PM
IntelGenx Technologies (1098880) Filer
Form QUALIF
02/14/2024 8:40 PM
IntelGenx Technologies (1098880) Filer
Form 1-A/A
02/14/2024 4:22 PM
IntelGenx Technologies (1098880) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/31/2024 3:12 PM
IntelGenx Technologies (1098880) Issuer
Zerbe Horst G (1381866) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024 2:50 PM
IntelGenx Technologies (1098880) Issuer
Melchers Bernd Josef (1478022) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024 2:51 PM
IntelGenx Technologies (1098880) Issuer
Pourhassan Zenoz Nina (2007605) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024 2:52 PM
IntelGenx Technologies (1098880) Issuer
Nawacki Mark (1685243) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024 2:55 PM
IntelGenx Technologies (1098880) Issuer
Kenny Tommy (1840932) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024 2:56 PM
IntelGenx Technologies (1098880) Issuer
Kalayajian Karen (1974392) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024 2:56 PM
Gorham Dwight (1974645) Reporting
IntelGenx Technologies (1098880) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024 2:58 PM
Godin Andre (1649546) Reporting
IntelGenx Technologies (1098880) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024 2:48 PM
IntelGenx Technologies (1098880) Issuer
Paiement Nadine (1665283) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2023 7:26 AM
IntelGenx Technologies (1098880) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/28/2023 3:18 PM
IntelGenx Technologies (1098880) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/16/2023 3:30 PM
IntelGenx Technologies (1098880) Filer
Form DEF 14A
10/12/2023 3:01 PM
IntelGenx Technologies (1098880) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/06/2023 8:22 PM
ATAI Life Sciences N.V. (1840904) Filed by
IntelGenx Technologies (1098880) Subject
Form SC 13D/A
09/05/2023 8:00 PM
ATAI Life Sciences AG (1776242) Reporting
ATAI Life Sciences N.V. (1840904) Reporting
IntelGenx Technologies (1098880) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)

IntelGenx Technologies SEC Filings - Frequently Asked Questions

IntelGenx Technologies (IGXT) has submitted 180+ filings to the SEC since 2017. You can browse the complete history or filter by form type using the tools above.

IntelGenx Technologies's fiscal year ends on December 31. The company typically files its 10-K annual report by the end of February, covering the prior fiscal year's financial results.

The most recent filing was a Form NT 10-Q submitted on August 14, 2024. View the full filing using the link above.

SEC Filing Types: 10-K, 10-Q, 8-K and More

SEC filings are legally required disclosures that public companies submit to the U.S. Securities and Exchange Commission. Unlike press releases or earnings call transcripts, these documents are filed under legal obligation — meaning the financial data they contain is audited, standardized, and subject to penalties if materially false. For investors, that makes SEC filings the most reliable primary source available for evaluating a company's true financial position.

Yes. All SEC filings are publicly available through the SEC's EDGAR database and on financial research platforms like MarketBeat. Companies are required by law to make these disclosures accessible to all investors — meaning retail investors have access to the same source documents as institutional analysts.

A 10-K is an annual report containing audited financial statements and a full review of the company's business — it is the most comprehensive filing a company makes each year. A 10-Q is a shorter, unaudited quarterly update filed three times per year between annual reports. Investors typically use the 10-K for deep fundamental analysis and the 10-Q to track whether the company is on pace with its guidance mid-year.

The most important filing for fundamental investors. Filed once per year, the 10-K contains audited financial statements, revenue and earnings trends, debt obligations, risk factors, and management's own assessment of the business. Reading the risk factors section and comparing year-over-year financials can reveal issues that don't show up in analyst summaries.

An unaudited financial update filed three times per year (the 10-K covers Q4). Investors use 10-Qs to track whether guidance is on pace, monitor changes in cash flow or inventory, and catch any mid-year shifts in business conditions before they become headline news.

Filed within four business days of a material event — earnings releases, merger announcements, executive departures, or major asset sales. Because 8-Ks are filed before media coverage catches up, they are often the fastest way to get unfiltered information directly from the company on market-moving events.

Filed within two business days whenever an executive or director buys or sells company stock. Insider purchases — especially large or clustered buys — are often interpreted as a signal of management confidence. Insider selling is more ambiguous but worth monitoring for patterns, particularly around lock-up expirations or ahead of major announcements.


Related Companies and Tools


SEC filings for OTCMKTS:IGXT are sourced directly from the U.S. Securities and Exchange Commission (SEC), with the most recent filing dated 8/14/2024. New filings are added as they're published.
From Our Partners